Advertisement
U.S. markets closed

Defence Therapeutics Inc. (DTC.CN)

Canadian Sec - Canadian Sec Real Time Price. Currency in CAD
0.5100-0.0100 (-1.92%)
At close: 12:33PM EST
Full screen
Previous Close0.5200
Open0.5500
Bid0.5100 x N/A
Ask0.5600 x N/A
Day's Range0.5100 - 0.5700
52 Week Range0.4800 - 2.8500
Volume32,031
Avg. Volume25,403
Market Cap24.014M
Beta (5Y Monthly)1.45
PE Ratio (TTM)N/A
EPS (TTM)-0.2600
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Newsfile

    Defence Announces Dr. Maxime Parisotto as CSO, Director of Science and Business Development

    Vancouver, British Columbia--(Newsfile Corp. - November 25, 2024) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) ("Defence" or the "Company"), a Canadian biopharmaceutical company developing radiopharmaceuticals and ADC products using its proprietary platform and drug delivery technologies in addition to novel immune-oncology vaccines, is pleased to announce that Dr. Maxime Parisotto has joined the Company as Chief Scientific Officer, Director of Science and Business Developmen

  • Newsfile

    Defence Announces Closing of Securities for Debenture Financing

    Vancouver, British Columbia--(Newsfile Corp. - November 22, 2024) - DEFENCE THERAPEUTICS INC. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) ("Defence" or the "Company"), a Canadian biopharmaceutical company developing radiopharmaceuticals and ADC products using its proprietary platform and drug delivery technologies in addition to novel immune-oncology vaccines, announces that it has closed its offering of unsecured convertible debentures (the "New Debentures") for aggregate gross proceeds of CAD$1,476,0